Longevity · mTOR inhibition
Rapamycin for longevity: what women in midlife should know
Rapamycin (sirolimus) inhibits mTORC1, a master regulator of cell growth and aging. It is the single molecule with the most consistent lifespan extension across yeast, worms, flies, and mice — including when started in midlife. Human off-label use for longevity is growing, and women's-health considerations are finally being studied.
Mechanism: hitting mTORC1 without mTORC2
mTORC1 senses nutrients and drives protein synthesis and cell growth. Chronic mTORC1 activation accelerates aging, promotes senescence, and impairs autophagy. Weekly rapamycin transiently inhibits mTORC1 without significantly hitting mTORC2 (which handles insulin signaling) — this is why intermittent dosing has a favorable metabolic profile.
The best human evidence to date
- Elderly humans given a rapamycin analog (RAD001) had improved vaccine response and reduced infection rates (Mannick et al., Sci Transl Med 2018).
- The PEARL trial (2024) showed improved lean body mass and pain in women taking 5–10 mg/week for 48 weeks.
Women's-health specifics
Rapamycin has been proposed to slow ovarian aging in reproductive-age women — small trials are underway. In perimenopausal and menopausal women, current use focuses on healthspan (immune function, body composition, cognitive resilience).
Frequently asked questions
Is rapamycin FDA-approved?
Yes — as an immunosuppressant for organ transplant. Use for longevity is off-label.
What dose is used for longevity?
Most longevity protocols use 3–6 mg once weekly, far below transplant doses (2–5 mg daily). Some physicians titrate up to 10 mg weekly.
Does rapamycin extend lifespan in humans?
Not proven in RCTs — those trials are only starting. In mice, weekly low-dose rapamycin extends lifespan by ~10–20% even when started in midlife.
Is rapamycin safe for women in menopause?
The main risks are mouth sores, delayed wound healing, hyperlipidemia, and glucose intolerance. Pulsed weekly dosing minimizes these. Rapamycin should not be used near surgery.
Rapamycin vs metformin for longevity?
Rapamycin has larger and more consistent lifespan effects in mice. Metformin has more human safety data at longevity doses. Some physicians combine them.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.